Atheroma: More than mush

Lancet

Volumn 348, Issue SUPPL.1, 1996, Pages

  Libby, Peter ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CELL ADHESION MOLECULE; CYTOKINE; VASCULAR CELL ADHESION MOLECULE 1;

ARTERY BLOOD FLOW; ARTICLE; ATHEROGENESIS; ATHEROMA; ATHEROSCLEROSIS; CELL FUNCTION; FIBROGENESIS; HUMAN; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VASCULAR ENDOTHELIUM;

EID: 0029849690     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)98002-2     Document Type: Article

References (17)

1. Falk E, Shah P, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-71.
2. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315: 1046-51.
3. Poole JCF, Florey HW. Changes in the endothelium of the aorta and the behaviour of macrophages in experimental atheroma of rabbits. J Pathol Bacteriol 1958; 75: 245-53.
4. Li H, Cybulsky MI, Gimbrone MA Jr, Libby P. An atherogenic diet rapidly induced VCAM-1, a cytokine regulatable mononuclear leukocyte adhesion molecule, in rabbit endothelium. Arteriosclerosis Thrombosis 1993; 13: 197-204.
5. Libby P, Ross R. Cytokines and growth regulatory molecules. In: Fuster V, Ross R, Topol E, eds. Atherosclerosis and coronary artery disease. New York: Lippincott-Raven, 1996; 5985-94.
6. Kume N, Cybulsky MI, Gimbrone MA Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteine, induces mononuclear leucocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 1992; 90: 1138-44.
7. Nelken N, Coughlin S, Gordon D, Wilcox J. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991; 88: 1121-27.
8. Metchnikoff E. The comparative pathology of inflammation. London: Kegan Paul, 1893.
9. Shaw GB. The doctors dilemma. London, 1911.
10. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 1983; 52: 223-61.
11. Geng Y-J, Libby P. Evidence for apoptosis in advanced human atheroma. Co-localization with interleukin-1 β-converting enzyme. Am J Pathol 1995; 147: 251-66.
12. Raines E, Rosenfeld M, Ross R. The role of the macrophage. In: Fuster V, Ross R, Topol E, eds. Atherosclerosis and coronary artery disease. New York: Lippincott-Raven, 1996: 539-68.
13. Libby P. The molecular bases of the acute coronary syndromes. Circulation 1995; 91: 2844-50.
14. Hansson G, Libby P. The role of the lymphocyte. In: Fuster V, Ross R, Topol E, eds. Atherosclerosis and coronary artery disease. New York: Lippincott-Raven, 1996: 557-68.
15. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-89.
16. Sheperd J, Cobbe S, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301-07.
17. Gerhard M, Ganz P. How do we explain the clinical benefits of estrogen? Circulation 1995; 92: 5-8.